Lab21 appoints new CEO
Advertisement
Lab21 has announced the appointment of Graham Mullis as its new CEO. Graham has held executive positions at FTSE and Nasdaq listed medical device companies including 1-800 Contacts Inc and Biocompatibles International PLC and pharmaceutical roles at Hoechst Roussel Ltd and R P Scherer Ltd. He has experience in successfully launching new businesses and technologies in healthcare markets, with IPO and extensive M&A experience at a variety of medical and pharmaceutical companies. Graham has an MBA from Warwick Business School and BSc in biochemistry with Physiology from Southampton University.
Graham joins Lab21 from Optivue Ltd, a company formed to develop and license pharmaceutical & medical device applications in optical products, where he is a co-founder.